Search Results – Inserm Transfert

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

BIO08305-T1

Drug Field of development:

Melanoma Therapy Area:

Product Type of patent:

Novel melanoma antigens

The invention relates to melanoma antigen named MELOE and their use for preventing, treating and diagnosing melanoma. […]

BIO1508601 -T1

Drug Field of development:

Immunology Therapy Area:

Target Type of patent:

Nanobody against ela2a to treat inflammatory bowel diseases (ibd) or

The invention is in the field of therapy of gut inflammatory diseases such as Inflammatory Bowel Diseases (IBD) or Irritable Bowel Syndrome (IBS) […]

BIO10412-T1

Drug Field of development:

Infectious Diseases Therapy Area:

Product Type of patent:

Recombinant flagellin for preventing and treating

The present invention relates to the use of an optimized truncated flagellin (TLR5 agonist devoided of toxic effect) for preventing or treating […]

BIO13284-T1

Drug Field of development:

Transplantation Therapy Area:

Method Type of patent:

Methods for expanding a population of alveolar macrophages in a long

The present invention relates to methods for expanding a population of alveolar macrophages in a long term culture. In particular, an object of the […]

BIO17685-T1

Drug Field of development:

Metabolic Disorders Therapy Area:

Product Type of patent:

Antigenic peptides deriving from urocortin 3 and uses thereof for the

Despite the notion that human CD8+ T cells are the final mediators of autoimmune ?- cell destruction in type 1 diabetes (T1D), none of their target […]

BIO21413-T1

Drug Field of development:

Oncology Therapy Area:

Biomarker Type of patent:

Methods and composition to identify and treat subjects resisting to

The present invention relates to a method for treating a subject suffering from a cancer comprising a step of administering said subject with a […]

BIO17059-T3

Drug Field of development:

Alzheimer’s disease Therapy Area:

Method Type of patent:

Pyk2-based gene therapy gene therapy attenuates cognitive deficits

In the present invention it is shown that the inactivation of the Pyk2 gene does not alter hippocampal development but prevents hippocampal-dependent […]

MECA11013-T1

Device Field of development:

Atrial Fibrillation Therapy Area:

Method Type of patent:

Transoesophageal device using high intensity focused ultrasounds for

The present invention relates to a probe comprising: a piezoelectric therapy transducer having an acoustic axis BB’, and an imaging transducer […]

BIO20216-T1

Dermatology Therapy Area:

Method Type of patent:

Use of il-36 inhibitors for the treatment of netherton syndrome

Netherton syndrome (NS) is a rare recessive skin disorder caused by loss-of-function mutations in SPINK5 encoding the protease inhibitor LEKTI. NS […]

BIO14015-T1

Drug Field of development:

Lung cancer Therapy Area:

Product Type of patent:

Anti-neurotensin mab for the treatment of cancer

The present invention relates to a neutralising antibody which is capable of binding to neurotensin with high affinity. The antibody of the present […]

147

56

310

46

Our Technology Offers

Novel melanoma antigens

Nanobody against ela2a to treat inflammatory bowel diseases (ibd) or

Recombinant flagellin for preventing and treating

Methods for expanding a population of alveolar macrophages in a long

Antigenic peptides deriving from urocortin 3 and uses thereof for the

Methods and composition to identify and treat subjects resisting to

Pyk2-based gene therapy gene therapy attenuates cognitive deficits

Transoesophageal device using high intensity focused ultrasounds for

Use of il-36 inhibitors for the treatment of netherton syndrome

Anti-neurotensin mab for the treatment of cancer

You might also be interested in

Method and apparatus for acquiring a spatial map

Ctip fusion to cas9 enhances transgene integration

Hla-class ii artificial antigen presenting cells

Quality control devices and methods for magnetic

Crispr barcoding: method and kit for labeling and

Methods and compositions for the preservation of

Method for universal detection and quantification

Methods and kits for detecting protein-protein

Inhibitors of the ceramide metabolic pathway

Lrrc33 as a biomarker and biotarget in cutaneous

Methods and composition to identify and treat

Garp as a biomarker and biotarget in t-cell